Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

NCT06435702 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Darolutamide in addition to androgen deprivation therapy
DRUG: androgen deprivation therapy only

Sponsor

Peking University Third Hospital

Collaborators

[object Object]